Good afternoon, and thank you very much for allowing the Canadian Livestock Genetics Association to make a presentation today.
For those of you who don't know, the Canadian Livestock Genetics Association looks into exporting live animal semen and embryos.
I'm going to outline some of the key challenges facing the Canadian genetics industry.
Basically, the loss of export markets for live animals is one of the key struggles we have been dealing with since BSE hit Canada. Of the live markets that are out there, Canada is no longer getting its share. The United States has really come ahead in marketing a lot of cattle, a lot more than we are in Canada have, percentage-wise.
With that comes a loss of the genetic and exporting infrastructure. We no longer have heifer growers. We no longer have exporters that do the marketing. Should we get a large market, we would be struggling to fulfill some of these markets with cattle, or otherwise
Canada is facing a high logistical cost for exporting live animals. We're not close to the markets anymore. The big market used to be the United States. It's no longer in North America, and it's very expensive to get cattle from Canada to other countries.
High-risk markets are becoming the norm. Those are markets like Kazakhstan, where they don't understand some of the current and modern animal health technologies—it's high risk for exporters doing business there—to working with countries like India, where they are developing also the same lines.
We see decreasing market development support, and that's becoming critical. We need to work hand in hand with our government to develop these markets. Industry is quite prepared to move forward in that direction, but we do need ongoing support from the government.
Capacity of the government agencies to accomplish technical negotiations in a timely manner is becoming very critical, and there are difficulties in negotiating health protocols to some of these emerging markets.
Those are some of the issue that we're facing.
I'm going to hit a couple of things to clarify and dig into them a little further, research being one of them. Research is a key to the long-term viability and seeing Canada as a leader in these markets. If we want to retain and regain that leadership role, we need to focus on research. We need a long-term commitment for funding to focus on genetic research and innovation. Our world-wide recognition that Canada is leadership is disappearing. The leading geneticists from Canada are now leaving the country. Where Canada used to be a magnet for genetic researchers, we're now seeing them move to other countries, like New Zealand and over to Europe. We're acutely aware of this and how it's going to affect our long-term viability. Other countries are basically building their research capacity using our best-trained people.
Moving to the Canadian Food Inspection Agency, we're seeing a growing lack of capacity to develop export certificates. Again, this is going to be critical in the future, as we work on new free trade agreements with countries. We seem to have a lack of capacity, less and less people to work on the details of some of these agreements.
We need to strengthen our focus on animal health issues and programs to lower disease prevalence. This is one of the key things. We have to be innovative in how we're going to do this, and we have to be out of the gate a lot faster than we have been.
Again, the Canadian Food Inspection Agency needs to be a partner with industry, and we need to make sure that our domestic animal health programs do not put our domestic industry at a global disadvantage. We can't make them too stringent, too tough, too hard for producers and exporters to be part of, and that's a concern.
We have to be able to utilize new technologies for disease testing and for export. These technologies are out there, but it seems slow to be adapted into government regulations.
We need a government that is ready to support industry by creating flexible programs to enhance our competitiveness through partnering and funding. I mentioned that earlier, and it's a big part of market development, but we need to be really innovative. Some of these smaller companies don't have access to the capital, so another item might be capital access for companies wanting to develop genetic exports.
We need to see our key negotiators travel to markets to support industry. Whether it's negotiating an animal health certificate, we need to be able to get them there to finalize these negotiations and get them completed.
We need a government that actively supports exporters in conflict resolution and defending its trade rules. We see that happening, and we need that to continue.
We need access to specialized funds and insurance programs for exporters that are now taking unparalleled risks. Some of these programs, through capital and insurance, can really make the difference in how we can see competitively around the world what we're going up against.
We would like to see the expanding of the much-needed funding in the AgriMarketing program—we have seen that decrease a bit over the years—and possibly more participants in it. It's a key program that our exporting industry uses to develop markets, so we have to be innovative in those new market developments and how we're going to get our share, how we're going to be the first in and get that market share.
We need supportive, innovative, leading research and development that focuses on improving the Canadian genetic products that other countries demand. I mentioned earlier that it's getting to the point where we're seeing our leading geneticists leave our country, so we need a long-term strategy for research.
Also, we need to reinvest in these key research platforms. Universities that want to cut leading researchers or not refill the positions when they retire are part of the problem. We need a long-term strategy on how to keep these key people.
We have to co-develop demonstration farms in key markets. I think this is a big part of what can really set Canada apart from other countries. We need to show our innovation and our genetics, but we need to profile them in the foreign country's conditions.
That kind of co-developing of a Canadian farm or of Canadian genetics benefits more than just the genetic industry. It also supports a broad group of Canadian agribusinesses that are involved in farm production. We see a lot of countries beating us out of the gate in these development strategies in other countries. Canada needs to be a little more innovative and a little quicker to get involved in some of these types of ventures.
All in all, the Canadian livestock genetics industry applauds the hard work done by the various governmental departments and Minister Ritz in aggressively opening new markets and promoting Canadian genetics around the world. The genetics industry has made excellent use of the AgriMarketing program for developing new markets and we would like to see this program strengthened. We also would like to see a long-term strategy to keep research in Canada and to regain our position as world leaders.
Again, the CLGA would like to thank the committee for letting us have this time.
Thank you.